A detailed history of Cambridge Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 930 shares of GILD stock, worth $86,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
930
Previous 875 6.29%
Holding current value
$86,090
Previous $70,000 2.86%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

BUY
$71.58 - $87.29 $3,936 - $4,800
55 Added 6.29%
930 $68,000
Q3 2023

Oct 26, 2023

SELL
$73.94 - $80.67 $4,436 - $4,840
-60 Reduced 6.42%
875 $65,000
Q2 2023

Jul 25, 2023

SELL
$76.01 - $86.7 $15,658 - $17,860
-206 Reduced 18.05%
935 $72,000
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $13,374 - $15,237
-173 Reduced 13.17%
1,141 $94,000
Q4 2022

Jan 09, 2023

SELL
$62.32 - $89.47 $3,739 - $5,368
-60 Reduced 4.37%
1,314 $113,000
Q3 2022

Nov 07, 2022

SELL
$59.54 - $68.01 $6,728 - $7,685
-113 Reduced 7.6%
1,374 $85,000
Q2 2022

Aug 16, 2022

SELL
$57.72 - $65.01 $5,021 - $5,655
-87 Reduced 5.53%
1,487 $92,000
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $23,341 - $29,249
-403 Reduced 20.38%
1,574 $94,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $128,267 - $145,586
1,977 New
1,977 $144,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.